Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
Details for Australian Patent Application No. 2002361168 (hide)
International Classifications
Event Publications
10 April 2003 Complete Application Filed
Priority application(s): 02019914.7 04.09.02 EP; 02000388.5 07.01.02 EP
4 September 2003 Application Open to Public Inspection
Published as AU-B-2002361168
23 August 2007 Assignment before Grant
Petzelt, Christian The application has been assigned to Cyplasin Biomedical, Ltd. Assignments before Grant, Section 113 2003
8 May 2008 Application Accepted
Published as AU-B-2002361168
4 September 2008 Standard Patent Sealed
27 May 2010 Assignment Registered
Cyplasin Biomedical, Ltd. The patent has been assigned to Bioxen Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002361169-Simultaneous riveting system of flat surfaces for riveters
2002361167-VALUABLE DOCUMENT AND METHOD AND DEVICE FOR EXAMINING SAID VALUABLE DOCUMENT
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser